Immune function in pregnancy: the role of corticotropin-releasing hormone

References

• Medawar PB. Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates: revention of allogenic fetal rejection by tryptophan catabolism. Symp. Soc. Exp. Biol.7, 320–338 (1953).
   Google Scholar
• Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science213(4514), 1394–1397 (1981).
   PubMed Web of Science ®Google Scholar
• Gravanis A, Makrigiannakis A, Zoumakis E, Margioris AN. Endometrial and myometrial corticotropin-releasing hormone (CRH): its regulation and possible roles. Peptides22(5), 785–793 (2001).
   Google Scholar
• Makrigiannakis A, Zoumakis E, Kalantaridou S et al. Corticotropin-releasing hormone (CRH) and immunotolerance of the fetus. Biochem. Pharmacol.65(6), 917–921 (2003).
   Google Scholar
• Makrigiannakis A, Minas V, Kalantaridou SN, Nikas G, Chrousos GP. Hormonal and cytokine regulation of early implantation. Trends Endocrinol. Metab.17(5), 178–185 (2006).
   PubMed Web of Science ®Google Scholar
• Grino M, Chrousos GP, Margioris AN. The corticotropin releasing hormone gene is expressed in human placenta. Biochem. Biophys. Res. Commun.148(3), 1208–1214 (1987).
   PubMed Web of Science ®Google Scholar
• Frim DM, Emanuel RL, Robinson BG, Smas CM, Adler GK, Majzoub JA. Characterization and gestational regulation of corticotropin-releasing hormone messenger RNA in human placenta. J. Clin. Invest.82(1), 287–292 (1988).
   PubMed Web of Science ®Google Scholar
• Jones SA, Brooks AN, Challis JR. Steroids modulate corticotropin-releasing hormone production in human fetal membranes and placenta. J. Clin. Endocrinol. Metab.68(4), 825–830 (1989).
   PubMed Web of Science ®Google Scholar
• Petraglia F, Tabanelli S, Galassi MC et al. Human decidua and in vitro decidualized endometrial stromal cells at term contain immunoreactive corticotropin-releasing factor (CRF) and CRF-messenger ribonucleic acid. J. Clin. Endocrinol. Metab.74(6), 1427–1431 (1992).
   PubMed Web of Science ®Google Scholar
• Makrigiannakis A, Zoumakis E, Margioris AN, Theodoropoulos P, Stournaras C, Gravanis A. The corticotropin-releasing hormone in normal and tumoral epithelial cells of human endometrium. J. Clin. Endocrinol. Metab.80(1), 185–193 (1995).
   PubMedGoogle Scholar
• Mastorakos G, Scopa CD, Kao LC et al. Presence of immunoreactive corticotropin releasing hormone in human endometrium. J. Clin. Endocrinol. Metab.81(3), 1046–1050 (1996).
   Google Scholar
• Chrousos GP, Torpy DJ, Gold PW. Interactions between the hypothalamic–pituitary–adrenal axis and the female reproductive system: clinical implications. Ann. Intern. Med.129(3), 229–240 (1998).
   PubMedGoogle Scholar
• Clifton VL, Telfer JF, Thompson AJ et al. Corticotropin-releasing hormone and proopiomelanocortin-derived peptides are present in human myometrium. J. Clin. Endocrinol. Metab.83(10), 3716–3721 (1998).
   PubMedGoogle Scholar
• Makrigiannakis A, Zoumakis E, Kalantaridou S et al. Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance. Nat. Immunol.2(11), 1018–1024 (2001).
   PubMed Web of Science ®Google Scholar
• Runic R, Lockwood CJ, Ma Y, Dipasquale B, Guller S. Expression of Fas ligand by human cytotrophoblasts: implications in placentation and fetal survival. J. Clin. Endocrinol. Metab.81(8), 3119–3122 (1996).
   PubMedGoogle Scholar
• Guleria I, Sayegh MH. Maternal acceptance of the fetus: true human tolerance. J. Immunol.178(6), 3345–3351 (2007).
   PubMed Web of Science ®Google Scholar
• Holmes CH, Simpson KL, Wainwright SD et al. Preferential expression of the complement regulatory protein decay accelerating factor at the fetomaternal interface during human pregnancy. J. Immunol.144(8), 3099–3105 (1990).
   Google Scholar
• Hsi BL, Hunt JS, Atkinson JP. Differential expression of complement regulatory proteins on subpopulations of human trophoblast cells. J. Reprod. Immunol.19(3), 209–223 (1991).
   Google Scholar
• Ishitani A, Sageshima N, Lee N et al. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal–placental immune recognition. J. Immunol.171(3), 1376–1384 (2003).
   PubMedGoogle Scholar
• King A, Burrows TD, Hiby SE et al. Surface expression of HLA-C antigen by human extravillous trophoblast. Placenta21(4), 376–387 (2000).
   PubMed Web of Science ®Google Scholar
• Munn DH, Zhou M, Attwood JT et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science281(5380), 1191–1193 (1998).
   PubMed Web of Science ®Google Scholar
• Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol.5(3), 266–271 (2004).
   PubMed Web of Science ®Google Scholar
• Zenclussen AC, Gerlof K, Zenclussen ML et al. Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4+CD25+ T regulatory cells prevents fetal rejection in a murine abortion model. Am. J. Pathol.166(3), 811–822 (2005).
   PubMed Web of Science ®Google Scholar
• Sasaki Y, Sakai M, Miyazaki S, Higuma S, Shiozaki A, Saito S. Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol. Hum. Reprod.10(5), 347–353 (2004).
   PubMed Web of Science ®Google Scholar
• Somerset DA, Zheng Y, Kilby MD, Sansom DM, Drayson MT. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology112(1), 38–43 (2004).
   PubMed Web of Science ®Google Scholar
• Guleria I, Khosroshahi A, Ansari MJ et al. A critical role for the programmed cell death ligand 1 in fetomaternal tolerance. J. Exp. Med.202 (2), 213–237 (2005).
   Google Scholar
• Vale W, Rivier C, Brown MR, Spiess J, Koob G, Swanson A. Chemical and biological characterization of corticotropin-releasing factor. Recent Prog. Horm. Res.39, 245–270 (1983).
   PubMedGoogle Scholar
• Antoni FA. Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor. Endocr. Rev.7(4), 351–378 (1986).
   PubMed Web of Science ®Google Scholar
• Orth D. Corticotropin-releasing hormone in humans. Endocr. Rev.13(2), 164–191 (1992).
   PubMed Web of Science ®Google Scholar
• Petrusz P, Merghenthaler I, Maderdrut L, Vigh S, Schally A. Corticotropin-releasing factor-like immunoreactivity in the vertebrate endocrine pancreas. Proc. Natl Acad. Sci. USA80(6), 1721–1725 (1983).
   PubMed Web of Science ®Google Scholar
• Suda T, Tomori N, Tozawa F, Mouri T, Demoura H, Shizume K. Distribution and characterization of immunoreactive corticotropin-releasing factor in human tissues. J. Clin. Endocrinol. Metab.59(5), 861–866 (1984).
   PubMedGoogle Scholar
• Petrusz P, Merghenthaler I, Ordronneau P, Maderdrudt L, Vigh S, Schally A. Corticotropin-releasing factor-like immunoreactivity in the gastro–entero–pancreatic endocrine system. Peptides5(Suppl. 1), 71–78 (1984).
   PubMed Web of Science ®Google Scholar
• Usui T, Nakai Y, Tsukada T, Jingami H, Takahashi H, Fucada J. Expression of adrenocoricotropin-releasing hormone precursor gene in placenta and other nonhypothalamic tissues in man. Mol. Endocrinol.2(9), 871–875 (1988).
   Google Scholar
• Owens MJ, Nemeroff CB. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev.43(4), 425–473 (1991).
   PubMed Web of Science ®Google Scholar
• Kalantaridou S, Makrigiannakis A, Zoumakis E, Chrousos GP. Peripheral corticotropin-releasing hormone is produced in the immune and reproductive systems: actions, potential roles and clinical implications. Front. Biosci.12, 572–580 (2007).
   PubMed Web of Science ®Google Scholar
• Chrousos GP. Reproductive placental corticotropin-releasing hormone and its clinical implications. Am. J. Obstet. Gynecol.180(Suppl.), 249–250 (1999).
   Google Scholar
• Makrigiannakis A, Margioris AN, Le Goascogne C et al. Corticotropin-releasing hormone (CRH) is expressed at the implantation sites of early pregnant rat uterus. Life Sci.57(20), 1869–1875 (1995).
   Google Scholar
• Ferrari A, Petraglia F, Gurpide E. Corticotropin-releasing factor decidualizes human endometrial stromal cells in vitro. Interaction with progestin. J. Steroid Biochem. Mol. Biol.54(5–6), 251–255 (1995).
   PubMed Web of Science ®Google Scholar
• Makrigiannakis A, Zoumakis E, Margioris AN, Stournaras C, Chrousos GP, Gravanis A. Regulation of the promoter of the human corticotropin-releasing hormone in transfected human endometrial cells. Neuroendocrinology64(2), 85–92 (1996).
   PubMed Web of Science ®Google Scholar
• Makrigiannakis A, Psychoyos A, Zoumakis E, Margioris AN, Stournaras C, Gravanis A. Endometrial corticotropin-releasing hormone: expression, regulation, and potential psychological implications. Ann. NY Acad. Sci.816, 116–128 (1997).
   PubMedGoogle Scholar
• Makrigiannakis A, Margioris AN, Zoumakis E, Stournaras C, Garvanis A. The transcription of corticotropin-releasing hormone in human endometrial cells is regulated by cytokines. Neuroendocrinology70(6), 451–459 (1999).
   PubMedGoogle Scholar
• Grammatopoulos DK, Hillhouse EW. Role of corticotropin-releasing hormone in onset of labour. Lancet354(9189), 1546–1549 (1999).
   PubMed Web of Science ®Google Scholar
• Donaldson CJ, Sutton SW, Corrigan AZ et al. Cloning and characterization of human urocortin. Endocrinology137(9), 2167–2170 (1996).
   PubMed Web of Science ®Google Scholar
• Zoumakis E, Grammatopoulos DK, Chrousos GP. Corticotropin-releasing hormone receptor antagonists. Eur. J. Endocrinol.155(Suppl. 1), S58–S91 (2006).
   Google Scholar
• Grammatopoulos DK, Chrousos GP. Functional characteristics of CRH receptors and potential clinical applications of CRH rerceptor antagonists. Trends Endocrinol. Metab.13(10), 436–444 (2002).
   PubMed Web of Science ®Google Scholar
• Di Blasio AM, Giraldi FP, Vigano P, et al. Expression of corticotropin-releasing hormone and its R1 receptor in human endometrial stromal cells. J. Clin. Endocrinol. Metab.82(5), 1594–1597 (1997).
   PubMed Web of Science ®Google Scholar
• Hillhouse EW, Grammatopoulos D, Milton NG, Quartero HW. The identification of a human myometrial corticotropin-releasing hormone receptor that increases in affinity during pregnancy. J. Clin. Endocrinol. Metab.76(3), 736–741 (1993).
   PubMedGoogle Scholar
• Jin D, He P, You X et al. Expression of corticotropin-releasing hormone receptor type 1 and type 2 in human pregnant myometrium. Reprod. Sci.14(6), 568–577 (2007).
   Google Scholar
• Grammatopoulos D, Milton NG, Hillhouse EW. The human myometrial CRH receptor: G proteins and second messengers. Mol. Cell. Endocrinol.99(2), 245–250 (1994).
   PubMedGoogle Scholar
• Grammatopoulos D, Thompson S, Hillhouse EW. The human myometrium express multiple isoforms of the corticotropin-releasing hormone receptor. J. Clin. Endocrinol. Metab.80(8), 2388–2393 (1995).
   PubMed Web of Science ®Google Scholar
• Grammatopoulos D, Stirrat GM, Williams SA, Hillhouse EW. The biological activity of the corticotropin-releasing hormone receptor-adenylate cyclate complex in human myometrium is reduced at the end of pregnancy. J. Clin. Endocrinol. Metab.81(2), 745–751 (1996).
   PubMed Web of Science ®Google Scholar
• Zoumakis E, Chatzaki E, Charalampopoulos I et al. Cycle and age-related changes in corticotropin-releasing hormone levels in human endometrium and ovaries. Gynecol. Endocrinol.15(2), 98–102 (2001).
   PubMed Web of Science ®Google Scholar
• Zoumakis E, Margioris A, Stournaras C, et al. Corticotropin-releasing hormone (CRH) interacts with inflammatory prostaglandins and interleukins and affects decidualization of human endometrial stroma. Mol. Hum. Reprod.6(4), 344–351 (2000).
   PubMedGoogle Scholar
• Makrigiannakis A, Margioris AN, Chatzaki E, Zoumakis E, Chrousos GP, Gravanis A. The decidualizing effect of progesterone may involve direct transcriptional activation of corticotrophin-releasing hormone from human endometrial stromal cells. Mol. Hum. Reprod.5(9), 789–796 (1999).
   PubMedGoogle Scholar
• Florio P, Rossi M, Sigurdardottir M et al. Paracrine regulation of endometrial function: interaction between progesterone and corticotropin-releasing factor (CRF) and activin A. Steroids68(10–13), 801–807 (2003).
   Google Scholar
• Frank GR, Brar AK, Jikihara H et al. Interleukin-1 β and the endometrium: an inhibitor of stromal cell differentiation and possible autoregulator of decidualization in humans. Biol. Reprod.52(1), 184–191 (1995).
   PubMed Web of Science ®Google Scholar
• Gill TJ. Immunological and genetic factors influencing pregnancy and development. Am. J. Reprod. Immunol. Microbiol.10(3), 116–120 (1986).
   Google Scholar
• Karalis K, Sano H, Redwine J, Listwak S, Wilder RL, Chrousos GP. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science254(5030), 421–423 (1991).
   PubMed Web of Science ®Google Scholar
• Sheth KV, Roca GL, al-Sedairy ST, Parhar RS, Hamilton CJ, al-Abdul Jabbar F. Prediction of successful embryo implantation by measuring interleukin-1-a and immunosuppressive factor(s) in preimplantation embryo culture fluid. Fertil. Steril.55(5), 952–957 (1991).
   PubMed Web of Science ®Google Scholar
• Lass A, Weiser W, Munafo A, Loumaye E. Leukemia inhibitory factor in human reproduction. Fertil. Steril.76(1), 1091–1096 (2001).
   PubMed Web of Science ®Google Scholar
• Nagata S. Fas and Fas ligand: a death factor and its receptor. Adv. Immunol.57, 129–144 (1994).
   PubMed Web of Science ®Google Scholar
• Suda T, Okazaki T, Naito Y et al. Expression of the Fas ligand in cells of T cell lineage. J. Immunol.154(8), 3806–3813 (1995).
   PubMed Web of Science ®Google Scholar
• Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC. A role for CD95 ligand in preventing graft rejection. Nature377(6550), 630–632 (1995).
   PubMed Web of Science ®Google Scholar
• Griffith TS, Yu X, Herndton JM, Green DR, Ferguson TA. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity5(1), 7–16 (1996).
   PubMed Web of Science ®Google Scholar
• Nagata S. Apoptosis by death factor. Cell88(3), 355–365 (1997).
   PubMed Web of Science ®Google Scholar
• Huang DC, Hahne M, Schroeter M et al. Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L). Proc. Natl Acad. Sci. USA96(26), 14871–14876 (1999).
   PubMed Web of Science ®Google Scholar
• Bamberger AM, Schulte HM, Thuneke I, Erdmann I, Bamberger CM, Asa SL. Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells. J. Clin. Endocrinol. Metab.82(9), 3173–3175 (1997).
   PubMed Web of Science ®Google Scholar
• Bamberger CM, Minas V, Bamberger AM et al. Expression of urocortin in the extravillous human trophoblast at the implantation site. Placenta28(2–3), 127–132 (2007).
   Google Scholar
• Athanasssakis I, Farmakiotis V, Aifantis I, Gravanis A, Vassiliadis S. Expression of corticotropin-releasing hormone in the mouse uterus: participation in embryo implantation. J. Endocrinol.163(2), 221–227 (1999).
   Google Scholar
• Psychoyos A. Uterine receptivity for nidation. Ann. NY Acad. Sci.476, 36–42 (1986).
   PubMed Web of Science ®Google Scholar
• Muglia L, Jacobson L, Dikkes P, Majzoub JA. Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature373 (6513), 427–432 (1995).
   PubMed Web of Science ®Google Scholar
• Turnbull AV, Smith GW, Lee S, Vale WW, Lee KF, Rivier C. CRF type I receptor-deficient mice exhibit a pronounced pituitary–adrenal response to local inflammation. Endocrinology140(2), 1013–1017 (1999).
   PubMed Web of Science ®Google Scholar
• Abrahams VM, Straszweski-Chavez SL, Guller S, Mor G. First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis. Mol. Hum. Reprod.10(1), 55–63 (2004).
   PubMed Web of Science ®Google Scholar
• Itoh N, Yonehara S, Ishii A et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell66(2), 233–243 (1991).
   PubMed Web of Science ®Google Scholar
• Yamashita H, Otsuki Y, Matsumoto K, Ueki K, Ueki M. Fas ligand, Fas antigen and Bcl-2 expression in human endometrium during the menstrual cycle. Mol. Hum. Reprod.5(4), 358–364 (1999).
   PubMedGoogle Scholar
• Phillips TA, Ni J, Pan G et al. TRAIL (Apo-2L) and TRAIL receptors in human placentas: implications for immune privilege. J. Immunol.162(10), 6053–6059 (1999).
   PubMed Web of Science ®Google Scholar
• Bamberger AM, Minas V, Kalantaridou SN et al. Corticotropin-releasing hormone modulates human trophoblast invasion through carcinoembryonic antigen-related cell adhesion molecule-1 regulation. Am. J. Pathol.168(1), 141–150 (2006).
   Google Scholar
• Thompson JA, Grunert F, Zimmerman W. Carcinoembryic antigen gene family: molecular biology and clinical perspectives. J. Clin. Lab. Anal.5(5), 344–366 (1991).
   PubMed Web of Science ®Google Scholar
• Bamberger AM, Sudahl S, Loning T et al. The adhesion molecule CEACAM1 (CD66a, C-CAM, BGP) is specifically expressed by the extravillous intermediate trophoblast. Am. J. Pathol.156(4), 1165–1170 (2000).
   Google Scholar
• McLean M, Bisits A, Davies J, Woods R, Lowry P, Smith R. A placental clock controlling the length of human pregnancy. Nat. Med.1(5), 460–463 (1995).
   PubMed Web of Science ®Google Scholar
• Riley SC, Walton JC, Herlick JM, Challis JR. The localization and distribution of corticotropin-releasing hormone in the human placenta and fetal membranes throughout gestation. J. Clin. Endocrinol. Metab.72(5), 1001–1007 (1991).
   PubMed Web of Science ®Google Scholar
• Challis JR, Matthews SG, Van Meir C, Ramirez MM. Current topic: the placental corticotropin-releasing hormone–adrenocorticotrophin axis. Placenta16(6), 481–502 (1995).
   Google Scholar
• Linton EA, Perkins AV, Woods RJ et al. Corticotropin releasing hormone-binding protein (CRH-BP): plasma levels during the third trimester of normal human pregnancy. J. Clin. Endocrinol. Metab.76(1), 260–262 (1993).
   PubMed Web of Science ®Google Scholar
• Magiakou MA, Mastorakos G, Rabin D, Dubbert B, Gold PW, Chrousos GP. Hypothalamic corticotropin releasing hormone suppression during the postpartum period: implications for the increase of psychiatric manifestations during this time. J. Clin. Endocrinol. Metab.81(5), 1912–1917 (1996).
   PubMed Web of Science ®Google Scholar
• Elenkov IJ, Wilder RL, Bakalov VK et al. Interleukin 12, tumor necrosis factor-a and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. J. Clin. Endocrinol. Metab.86(10), 4933–4938 (2001).
   PubMed Web of Science ®Google Scholar
• Sirianni R, Mayhew BA, Carr BR, Parker CR Jr, Rainey WE. Corticotropin-releasing hormone (CRH) and urocortin act through type 1 CRH receptors to stimulate dehydroepiandrosterone sulfate production in human fetal adrenal cells. J. Clin. Endocrinol. Metab.90(9), 5393–5400 (2005).
   PubMed Web of Science ®Google Scholar
• Petraglia F, Sutton S, Vale W. Neurotransmitters and peptides modulate the release of immunoreactive corticotropin releasing factor from cultured human placental cells. Am. J. Obstet. Gynecol.160(1), 247–251 (1989).
   PubMed Web of Science ®Google Scholar
• Petraglia F, Garuti GC, De Ramundo B, Angioni S, Genazzani AR, Bilezikjian LM. Mechanism of action of interleukin-1 β is increasing corticotropin-releasing factor from cultured human placental cells. Am. J. Obstet. Gynecol.163(4 Pt 1), 1307–1312 (1990).
   PubMed Web of Science ®Google Scholar
• Fourestie V, De Lignieres B, Roudot-Thoraval F et al. Suicide attempts in hypo-estrogenic phases of the menstrual cycle. Lancet2(8520), 1357–1360 (1986).
   PubMed Web of Science ®Google Scholar
• Robinson BG, Emanuel RL, Frim DM, Majzoub JA. Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta. Proc. Natl Acad. Sci. USA85(14), 5244–5248 (1988).
   PubMed Web of Science ®Google Scholar
• Goland RS, Conwell IM, Jozak S. The effect of preeclampsia on human placental corticotropin-releasing hormone content and processing. Placenta16(4), 375–382 (1995).
   PubMedGoogle Scholar
• Ni X, Nicholson RC, King BR, Chan EC, Read MA, Smith R. Estrogen represses whereas the estrogen-antagonist ICI 182780 stimulates placental CRH gene expression. J. Clin. Endocrinol. Metab.87(8), 3774–3778 (2002).
   Google Scholar
• Challis JRG, Matthews SG, Gibb W, Lye SJ. Endocrine and paracrine regulation of birth at term and preterm. Endocr. Rev.21(5), 514–550 (2000).
   PubMed Web of Science ®Google Scholar
• Li W, Challis JR. Corticotropin-releasing hormone and urocortin induce secretion of matrix metalloproteinase-9 (MMP-9) without change in tissue inhibitors of MMP-1 by cultured cells from human placenta and fetal membranes. J. Clin. Endocrinol. Metab.90(12), 6569–6574 (2005).
   PubMed Web of Science ®Google Scholar
• Markovic D, Vatish M, Gu M et al. The onset of labor alters corticotropin-releasing hormone type 1 receptor variant expression in human myometrium: putative role of interleukin-1β. Endocrinology148(7), 3205–3213 (2007).
   PubMed Web of Science ®Google Scholar
• Karalis K, Goodwin G, Majzoub JA. Cortisol blockade of progesterone: a possible molecular mechanism involved in the initiation of human labor. Nat. Med.2(5), 556–560 (1996).
   PubMedGoogle Scholar
• Yang R, You X, Tang X, Gao L, Ni X. Corticotropin-releasing hormone inhibits progesterone production in cultured human placental trophoblasts. J. Mol. Endocrinol.37(3), 533–540 (2006).
   PubMed Web of Science ®Google Scholar
• Jeschke U, Mylonas I, Richter DU et al. Regulation of progesterone production in human term trophoblasts in vitro by CRH, ACTH and cortisol (prednisolone). Arch. Gynecol. Obstet.272(1), 7–12 (2005).
   PubMedGoogle Scholar
• Macklon NS, Geraedts JP, Fauser BC. Conception to ongoing pregnancy: the ‘black box’ of early pregnancy loss. Hum. Reprod. Update8(4), 333–343 (2002).
   PubMed Web of Science ®Google Scholar
• Minas V, Jeschke U, Kalantaridou SN et al. Abortion is associated with increased expression of FasL in decidual leukocytes and apoptosis of extravillous trophoblasts: a role for CRH and urocortin. Mol. Hum. Reprod.13(9), 663–73 (2007).
   PubMed Web of Science ®Google Scholar
• Sibai BM. Preeclampsia as a cause of preterm and late preterm (near-term) births. Semin. Perinatol.30(1), 16–19 (2006).
   PubMed Web of Science ®Google Scholar
• Mari G, Hanif F. Intrauterine growth restriction: how to manage and when to deliver. Clin. Obstet. Gynecol.50(2), 497–509 (2007).
   PubMedGoogle Scholar
• Kinzler WL, Kaminsky L. Fetal growth restriction and subsequent pregnancy risks. Semin. Perinatol.31(3), 126–134 (2007).
   PubMed Web of Science ®Google Scholar
• Schiessl B. Inflammatory response in preeclampsia. Mol. Aspects Med.28(2), 210–219 (2007).
   PubMed Web of Science ®Google Scholar
• Rusterholz C, Hahn S, Holzgreve W. Role of placentally produced inflammatory and regulatory cytokines in pregnancy and the etiology of preeclampsia. Semin. Immunopathol.29(2), 151–162 (2007).
   PubMed Web of Science ®Google Scholar
• Clifton VL, Read MA, Leitch IM et al. Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: involvement of the nitric oxide–cyclic guanosine 3´,5´-monophosphate-mediated pathway. J. Clin. Endocrinol. Metab.80(10), 2888–2893 (1995).
   PubMed Web of Science ®Google Scholar
• Perkins AV, Linton EA, Eben F, Simpson J, Wolfe CD, Redman CW. Corticotropin-releasing hormone and corticotropin-releasing hormone binding protein in normal and pre-eclamptic human pregnancies. Br. J. Obstet. Gynaecol.102(2), 118–122 (1995).
   PubMedGoogle Scholar
• Karteris E, Goumenou A, Koumantakis E, Hillhouse EW, Grammatopoulos DK. Preeclampsia is associated with impaired regulation of the placental nitric oxide–cyclic guanosine monophosphate pathway by corticotropin-releasing hormone (CRH) and CRH-related peptides. J. Clin. Endocrinol. Metab.88(1), 363–370 (2003).
   PubMedGoogle Scholar
• Karteris E, Vatish M, Hillhouse EW, Grammatopoulos DK. Preeclampsia is associated with impaired regulation of the placental nitric oxide–cyclic guanosine monophosphate pathway by corticotropin-releasing hormone (CRH) and CRH-related peptides. J. Clin. Endocrinol. Metab.90(6), 3680–3687 (2005).
   PubMed Web of Science ®Google Scholar
• Wadhwa PD, Garite TJ, Porto M et al. Placental corticotropin-releasing hormone (CRH), spontaneous preterm birth, and fetal growth restriction: a prospective investigation. Am. J. Obstet. Gynecol.191(4), 1063–1069 (2004).
   PubMed Web of Science ®Google Scholar
• Goland RS, Jozak S, Warren WB, Conwell IM, Stark RI, Tropper PJ. Elevated levels of umbilical cord plasma corticotropin-releasing hormone in growth-retarded fetuses. J. Clin. Endocrinol. Metab.77(5), 1174–1179 (1993).
   PubMed Web of Science ®Google Scholar
• Eide IP, Isaksen CV, Salvesen KA et al. Fetal growth restriction is associated with reduced FasL expression by decidual cells. J. Reprod. Immunol.74(1–2), 7–14 (2007).
   PubMed Web of Science ®Google Scholar
• Goldenberg RL, Rouse DJ. Prevention of preterm birth. N. Engl J. Med.339(5), 313–130 (1998).
   PubMed Web of Science ®Google Scholar
• Korebrits C, Ramirez MM, Watson L, Brinkman E, Bocking AD, Challis JR. Maternal corticotropin-releasing hormone is increased with impending preterm birth. J. Clin. Endocrinol. Metab.83(5), 1585–1591 (1998).
   PubMed Web of Science ®Google Scholar
• Makrigiannakis A, Semmler M, Briese V et al. Maternal serum corticotropin-releasing hormone and ACTH levels as predictive markers of premature labor. Int. J. Gynaecol. Obstet.97(2), 115–119 (2007).
   PubMed Web of Science ®Google Scholar